Brind.

Mylan plans to sell up to 92 million shares in Biocon.

1 report, 1 independent Updated Jul 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Biocon Mylan

Keep exploring

The entities involved

Biocon
an Indian biopharmaceutical company

Nothing else this week.
Mylan
former pharmaceutical company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01

Coverage

Newest first; wire copies grouped

Jul 14moneycontrol.com